Use of calcium channel antagonists in myocardial revascularization procedures.
Calcium channel antagonists possess a number of properties that may be beneficial after revascularization procedures. Therefore, we present an overview of the use of these drugs after percutaneous intervention in the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT), and compare the results in CAVEAT with those in published randomized trials. Also reviewed are the use of calcium channel antagonists to control perioperative hypertension, reduce myocardial necrosis, and prevent arrhythmias during cardiopulmonary bypass.
Califf
R M
RM
Clinical Research Institute, Duke University Medical Center, Durham, North Carolina 27710, USA.
Tardiff
B E
BE
Pieper
K S
KS
Hillegass
W B
WB
D015906:Angioplasty, Balloon, Coronary; D017073:Atherectomy; D002121:Calcium Channel Blockers / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D003327:Coronary Disease / Q000628:therapy*; D006801:Humans; D009204:Myocardial Revascularization / Q000379:methods*; D016032:Randomized Controlled Trials as Topic; D012008:Recurrence
D002121:Calcium Channel Blockers